Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Tests pulmonary rehabilitation for rural people with COPD

Tests a lung rehabilitation program for rural adults with chronic obstructive pulmonary disease.

Plain-language title generated from the registry record
Registry title: Pulmonary Rehabilitation for Rural Patients With COPD

Key facts

Where
Rochester and Scottsdale, United StatesSee the 2 sites

Where in United States

  • Mayo Clinic in RochesterRochester, United StatesTaking people
  • Mayo Clinic in ArizonaScottsdale, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Mayo Clinic
Trial code
NCT06847061
Record updated
7 May 2026
Original description
The purpose of this study is to test the uptake, effectiveness, and patient-caregiver-provider experience of a crucial treatment not provided in rural areas: pulmonary rehabilitation.Read full original descriptionShow less

Decreasing Disparity in Lung Disease: Pulmonary Rehabilitation for Rural Patients With COPD

The purpose of this study is to test the uptake, effectiveness, and patient-caregiver-provider experience of a crucial treatment not provided in rural areas: pulmonary rehabilitation.

Inclusion: 40 years of age or older; Physician-diagnosed COPD; Living in a rural area defined by Rural-Urban Commuting Area Codes 4-10; mMRC score>=1; English Speaking.

Exclusion: Patients with no COPD symptom burden, no breathlessness (mMRC score 0), as based on our previous studies they usually perceive no benefit from PR and do not have compliance with PR; Inability to walk (orthopedic/neurologic/cardiac limitation causing immobility); Cognitive impairment or inability to understand and follow instructions; Traditional center-based PR was completed within 3 months of initial study recruitment; Transition to hospice or end-of-life care at the time of screening; Acute exacerbation at the time of screening.

ClinicalTrials.gov NCT06847061